StockData
Stryker Corp logo

Stryker Corp (SYK) stock

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3017% below fair value
$318.15+0.61 (+0.19%)

Close on Nov 18, 2026Market cap $121.12BP/E 33.9Yield –

Stryker revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Stryker's revenue for the twelve months ending Sep 30, 2026 was $26.30B, up 7.9% year over year. For fiscal 2025 it was $25.12B, up 11.2% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $25.12B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.12B+11.2%
FY2024Dec 31, 2024$22.60B+10.2%
FY2023Dec 31, 2023$20.50B+11.1%
FY2022Dec 31, 2022$18.45B+7.8%
FY2021Dec 31, 2021$17.11B+19.2%
FY2020Dec 31, 2020$14.35B-3.6%
FY2019Dec 31, 2019$14.88B+9.4%
FY2018Dec 31, 2018$13.60B+9.3%
FY2017Dec 31, 2017$12.44B+9.9%
FY2016Dec 31, 2016$11.33B+13.9%
FY2015Dec 31, 2015$9.95B+2.8%
FY2014Dec 31, 2014$9.68B+7.2%
FY2013Dec 31, 2013$9.02B+4.2%
FY2012Dec 31, 2012$8.66B+4.2%
FY2011Dec 31, 2011$8.31B+13.5%
FY2010Dec 31, 2010$7.32B+8.9%
FY2009Dec 31, 2009$6.72B+0.1%
FY2008Dec 31, 2008$6.72B+12.0%
FY2007Dec 31, 2007$6.00B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$6.52B+7.6%
Q2 FY2026Jun 30, 2026$6.59B+9.4%
Q1 FY2026Mar 31, 2026$6.02B+2.6%
Q4 FY2025Dec 31, 2025$7.17B+11.4%
Q3 FY2025Sep 30, 2025$6.06B+10.2%
Q2 FY2025Jun 30, 2025$6.02B+11.1%
Q1 FY2025Mar 31, 2025$5.87B+11.9%
Q4 FY2024Dec 31, 2024$6.44B+10.7%
Q3 FY2024Sep 30, 2024$5.49B+11.9%
Q2 FY2024Jun 30, 2024$5.42B+8.5%
Q1 FY2024Mar 31, 2024$5.24B+9.7%
Q4 FY2023Dec 31, 2023$5.82B+11.8%
Q3 FY2023Sep 30, 2023$4.91B+9.6%
Q2 FY2023Jun 30, 2023$5.00B+11.2%
Q1 FY2023Mar 31, 2023$4.78B+11.8%
Q4 FY2022Dec 31, 2022$5.20B+10.7%
Q3 FY2022Sep 30, 2022$4.48B+7.7%
Q2 FY2022Jun 30, 2022$4.49B+4.6%
Q1 FY2022Mar 31, 2022$4.28B+8.1%
Q4 FY2021Dec 31, 2021$4.70B+10.3%
Q3 FY2021Sep 30, 2021$4.16B+11.3%
Q2 FY2021Jun 30, 2021$4.29B+55.4%
Q1 FY2021Mar 31, 2021$3.95B+10.2%
Q4 FY2020Dec 31, 2020$4.26B+3.2%
Q3 FY2020Sep 30, 2020$3.74B+4.2%
Q2 FY2020Jun 30, 2020$2.76B-24.3%
Q1 FY2020Mar 31, 2020$3.59B+2.0%
Q4 FY2019Dec 31, 2019$4.13B+8.8%
Q3 FY2019Sep 30, 2019$3.59B+10.6%
Q2 FY2019Jun 30, 2019$3.65B+9.9%
Q1 FY2019Mar 31, 2019$3.52B+8.5%
Q4 FY2018Dec 31, 2018$3.80B+9.4%
Q3 FY2018Sep 30, 2018$3.24B+7.9%
Q2 FY2018Jun 30, 2018$3.32B+10.3%
Q1 FY2018Mar 31, 2018$3.24B+9.7%
Q4 FY2017Dec 31, 2017$3.47B+9.9%
Q3 FY2017Sep 30, 2017$3.01B–
Q2 FY2017Jun 30, 2017$3.01B–
Q1 FY2017Mar 31, 2017$2.96B–
Q4 FY2016Dec 31, 2016$3.16B–

More Stryker figures

See a number that looks wrong?